CLRB- It spiked due to a patent news. It just had a financing round recently, raising 7.2million and complied to NASDAQ listing criteria, which is good. But there are exercisable warrants at 2.13 per share which allows them to sell into this spike. It has terrible long term chart and price action just like KOOL few days ago. Its at midrange now, breakout is 3.90 and support at 3.05. I will only buy it if it breaks out or dip buy it at 2.60 as there’s support there. I think this should come down on Monday, but I will react according to price action.
Breakout play:
EP: 3.90 (whole candle breaks through in 1 min chart)
SL: 3.80
TP: 4.30
R-R: 4:1
Dip buy play:
EP: 2.50 (ideally)-2.60
SL: 10 cents a share
TP: 2.90
R-R 4:1
ORIG- Weak earnings winner. I dip bought at 2.30 in the morning and ride it up to 2.44 but didn’t want to take profits as I thought it could squeeze in the afternoon as it’s a Friday. It did a bit to 2.39 but didn’t do much. I also put a hard stop at 2.24 and it got taken out in 1 second then spike back up to 2.30. Now I know why Tim says never put hard stops. I should have taken profits earlier as later that day, there was just so many huge sellers. If this can hold 2.20 and with less huge sellers, it can spike back up to 2.50.
EP: 2.20
SL: 2.15
TP: 2.50
R-R: 6:1
BBEP- I think its just a short squeeze as it is about to be delisted from NASDAQ on 25/5/2016 https://biz.yahoo.com/e/160518/bbep8-k.html. But if they appeal for it, I think this can spike back up to 0.15. as it closed above the multi day breakout level of 0.07. There are intraday resistance at 0.10 but if the news is there, I think there will be higher volume and pushes the stock back up under the longer term resistance at 0.15. This could be a 100% win!
EP: 0.09
SL: 0.08
TP: 0.15
R-R: 6:1
ARP- First green day after multiple down days due to earnings loser. I think this could retest 0.35 on Monday, if it breaks 0.30.
EP: 0.30
SL: 0.29
TP: 0.35
R-R: 5:1
CVGI- It had a solid uptrend from 2.19 for past week and it has finally broken the recent range with huge volume I think this could retest 3.70. I will look to dip buy this at 3.32 if it can hold it. I won’t chase it at 3.50 as there’s only 20 cents of upside. If it dips back down to 3.30 then I will have 40 cents of upside and less risk as I would know if 3.30 level doesn’t hold, then the breakout has failed. But the way it closes, it is unlikely to fail.
EP: 3.33-3.35
SL: 3.25
TP: 3.75
R-R: 4:1
ARRY- It closed at its high. If it can break 3.37 or holds 3.22, then it can retest 3.70s. It will present at the American Society of Clinical Oncology annual meeting on 3rd of June regarding its new drug and they are planning to submit a new drug application next month. When the press release came out, the stock uptrended. This should be a good buy until the meeting.
Break out play:
EP: 3.38-3.40
SL: 3.30
TP: 3.75
R-R: 3:1
Dip buy play:
EP: 3.23
SL: 3.25
TP: 3.70 (if it can breakout pass 3.37)
R-R: 5:1